The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity
Status: | Recruiting |
---|---|
Conditions: | Ocular, Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 30 - 90 |
Updated: | 4/21/2016 |
Start Date: | November 2014 |
End Date: | December 2016 |
The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity Outcomes In Cases Undergoing Cataract Surgery: A Pilot Study.
This is a randomized, masked, placebo controlled study to assess the effect on visual
acuity, if any, of the PRN omega-3 nutritional supplement in subjects undergoing cataract
surgery.
acuity, if any, of the PRN omega-3 nutritional supplement in subjects undergoing cataract
surgery.
Inclusion Criteria:
- Presence of nuclear or cortical lens opacities in one/both eyes
- Physician diagnosis of age related cataract
- Good overall physical constitution
- All participants must be follow the same regimen for surgery related medications,
both pre and post surgery. (Antibiotic, NSAID and Steroid eye drops)
Exclusion Criteria:
- Subjects requiring Premium IOLs/multifocal implants
- Advanced cataract
- Severe Age-Related Macular Degeneration Presence or history of Glaucoma
- Presence or history of Diabetes Mellitus
- Any Retinal pathology - retinal detachment, retinitis pigmentosa, diabetic
retinopathy, etc
- Vision loss due to Central retinal artery occlusion or Central retinal vein occlusion
- Vision loss due to presence of large pituitary tumors or aneurysms
- Vision loss due to optic tract lesions
- Vision loss due to bleeding into aqueous or vitreous chamber
- Vision loss due to drug toxicity: Amiodarone, anti-tuberculosis drugs,
hydroxychloroquine, tamoxifen
- Major cardiovascular or cerebral events in the past 12 months
- Allergy to fish oil or safflower oil
- Pregnancy or lactation at any time during the study
- Newly started or increased the dose of chronic systemic medication known to affect
tear production including, but not limited to antihistamines, antidepressants,
diuretics, corticosteroids or immunomodulators within 30 days of Screening or at any
time during the study
- Participation in any other study involving an investigational drug or device within
the past 30 days
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials